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Abstract
Background: Regulating synthesis of the Fragile X gene (FMR1) product, FMRP alters neural
plasticity potentially through its role in the microRNA pathway. Cap-dependent translation of the
FMR1 mRNA, a process requiring ribosomal scanning through the 5' leader, is likely impeded by
the extensive secondary structure generated by the high guanosine/cytosine nucleotide content
including the CGG triplet nucleotide repeats in the 5' leader. An alternative mechanism to initiate
translation – internal initiation often utilizes secondary structure to recruit the translational
machinery. Consequently, studies were undertaken to confirm and extend a previous observation
that the FMR1 5' leader contains an internal ribosomal entry site (IRES).
Results: Cellular transfection of a dicistronic DNA construct containing the FMR1 5' leader
inserted into the intercistronic region yielded significant translation of the second cistron, but the
FMR1 5' leader was also found to contain a cryptic promoter possibly confounding interpretation
of these results. However, transfection of dicistronic and monocistronic RNA ex vivo or in vitro
confirmed that the FMR1 5' leader contains an IRES. Moreover, inhibiting cap-dependent translation
ex vivo did not affect the expression level of endogenous FMRP indicating a role for IRES-dependent
translation of FMR1 mRNA. Analysis of the FMR1 5' leader revealed that the CGG repeats and the
5' end of the leader were vital for internal initiation. Functionally, exposure to potassium chloride
or intracellular acidification and addition of polyinosinic:polycytidylic acid as mimics of neural
activity and double stranded RNA, respectively, differentially affected FMR1 IRES activity.
Conclusion: Our results indicate that multiple stimuli influence IRES-dependent translation of the
FMR1 mRNA and suggest a functional role for the CGG nucleotide repeats.
Background
The mRNA and protein generated from the FMR1 gene in
neurons is localized to dendrites [1,2]. The FMR1 protein,
FMRP is synthesized in response to neural activity and its
function as an RNA binding protein influences the trans-
lational level of other dendritically localized mRNAs [3-
6]. FMRP is also part of the RISC complex [7,8], a set of
proteins that interact with micro-RNAs or short interfering
RNAs to inhibit translation and or degrade the RNA,
respectively.
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Regulating the synthesis of FMRP is important for cellular
function. FMRP over-expression leads to a defect in den-
dritic architecture, synaptic differentiation, and abnormal
behaviors in mice and flies [9,10]. Alternatively, the
absence of FMRP in Fragile X Syndrome (FXS) leads to
alterations in synaptic plasticity resulting in mental retar-
dation [11]. FXS develops from an expansion of the CGG
nucleotide repeats in the 5' leader of the FMR1 gene [12-
14]. Normal individuals carry from 5 – 50 repeats while
those with FXS carry over 200 repeats. The expansion
increases methylation of the gene inhibiting transcription.
In some cases transcription of the gene occurs [15,16], but
translation of the mRNA is inhibited by the presence of
the CGG repeat expansion [17]. The CGG repeats are evo-
lutionarily conserved in mammals suggesting that the
repeats have some function aside from inhibiting tran-
scription and translation [18].
During post-transcriptional gene processing, a 7-methyl
guanosine (termed the cap structure) is positioned at the
5' end of an mRNA [19]. All mRNAs can potentially be
translated by the eukaryotic initiation factor (eIF) 4E
binding to the cap structure and recruiting the remainder
of the translational machinery including the ribosome
[20]. On the other hand, a subset of mRNAs initiate trans-
lation in a cap-independent manner through internal
ribosomal entry sites (IRESes) situated in the 5' leader and
in some cases in the open reading frame [21,22]. IRES-
dependent translation is thought to be utilized when cap-
dependent translation is inhibited. This occurs during
normal physiological processes including mitosis, but
also in response to stressful events such as apoptosis [23-
25]. It may also be a primary translational mechanism
that can be regulated independently of pathways affecting
cap-dependent translation. In the nervous system, numer-
ous dendritically localized mRNAs contain IRESes includ-
ing those coding for the alpha subunit of CAMKII,
activity-related cytoskeletal protein, and the neurotrophin
receptor TrkB [26,27]. The high preponderance of dendrit-
ically localized mRNAs containing IRESes suggests that
IRES-dependent translation is an important protein syn-
thesis mechanism in dendrites.
Our goals were to confirm a previous study that the FMR1
5' leader mediates internal initiation of translation [28],
identify regions in the FMR1 5' leader critical for IRES
activity, and to determine if FMR1 IRES activity is affected
by cellular processes in which FMRP participates. Initially,
we re-examined the FMR1 5' leader for IRES activity and
found that it contained a cryptic promoter, compelling
the use of RNA constructs. Translation assays using RNA
both in vitro and ex vivo demonstrated that the FMR1 5'
leader does contain an IRES and that IRES-dependent
translation may be an important mechanism for the syn-
thesis of FMRP in vivo. A dissection of the 5' leader showed
that the 5' 45 nucleotides (nt) as well as the CGG repeats
are important for internal initiation. Finally, multiple cel-
lular stimuli including exposure to KCl and intracellular
acidification as models for neural activity and exposure to
polyinosinic:polycytidylic acid as a model for the pres-
ence of double stranded RNA resulted in alterations of
FMR1 IRES activity.
Results
The FMR1 5' leader directs expression of the second 
cistron in a dicistronic DNA construct
Viral IRESes are denoted by being relatively long (> 200
nt), guanosine/cytosine (G/C) nt rich, and containing
upstream open reading frames (uORFs). The FMR1 5'
leader exhibits a subset of these characteristics being
approximately 240 nt (depending upon the number of
CGG repeats) and is > 80% G/C rich, but it does not con-
tain any uORFs. To confirm a previous report that the
FMR1 5' leader contained an IRES [28], the leader was
inserted into the intercistronic region of a dicistronic luci-
ferase construct. Two negative controls were used, the
multiple cloning site (MCS) in the intercistronic region
(pRF) and the β-globin 5' leader. The β-globin 5' leader
was chosen since the β-globin mRNA is translated exclu-
sively in a cap-dependent manner [29]. The encephalomy-
ocarditis (EMCV) virus IRES was chosen as the positive
control [30]. The constructs were transfected into the C6
glioma and N2a neuroblastoma cell lines. After 24 hrs the
cells were harvested and assayed for Renilla and Photinus
luciferase. The Photinus:Renilla  luciferase (P:R) ratio
obtained from the control dicistronic construct (pRF) was
normalized to one. A ratio above one would indicate IRES
activity. Both the EMCV IRES and the FMR1 5' leader
exhibited P:R ratios significantly higher than that
observed from the pRF (and β-globin) construct. Indeed,
the P:R ratio obtained from the FMR1 5' leader was
approximately 30 and 60 fold higher in C6 and N2a cells
respectively (Fig. 1A). The level of FMR1 IRES activity was
higher than that observed from the EMCV IRES. This ini-
tial result suggests that the FMR1 5' leader may contain an
IRES.
The FMR1 5' leader contains a cryptic promoter
In addition to internal initiation, increased levels of Photi-
nus  luciferase protein can be generated from the dicis-
tronic luciferase constructs through cryptic splicing or
cryptic promoter activity. For example, the presence of a
cryptic promoter in the 5' leader will lead to the produc-
tion of a monocistronic Photinus luciferase mRNA [31,32]
and artificially increase the P:R ratio. To determine if cryp-
tic promoter activity was present in the FMR1 5' leader,
the dicistronic luciferase constructs with or without the
SV40 promoter and intron were transfected into C6 cells.
Photinus  luciferase activity from the promoterless con-
structs containing the pRF MCS, β-globin 5' leader, andBMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
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EMCV IRES was very low, less than 1% of the Photinus
luciferase activity obtained from the constructs with the
intact promoter. This result confirms previous studies
indicating that these leaders do not contain a cryptic pro-
moter [26,33]. However, the promoterless construct con-
taining the FMR1 5' leader generated approximately 15%
of the 'total' Photinus luciferase activity. After subtracting
the minor contribution of the cryptic promoter to the
translation of the second cistron, the data still suggests
that the FMR1 5' leader has an IRES, but it does temper
this conclusion.
The FMR1 5' leader exhibits IRES activity from a 
dicistronic RNA
To determine more unambiguously whether the FMR1 5'
leader contains an IRES, the dicistronic constructs were
transcribed in vitro eliminating the possibility of alterna-
tive splicing and alternate promoters. Transfecting the
mRNA into C6 cells did provide evidence of IRES activity
(Fig. 2A). The P:R ratio obtained from the dicistronic luci-
ferase mRNA containing the FMR1 5' leader was approxi-
mately 4.5 fold higher than the β-globin control.
Although the P:R ratio generated from the FMR1 5' leader
was substantially lower when comparing the RNA to DNA
transfections, the results still indicate that the FMR1 5'
leader contains an IRES.
Translation of a monocistronic mRNA in vitro and ex vivo 
indicates a key role for IRES-dependent translation 
mediated by the FMR1 5' leader
The dicistronic luciferase assay is useful to identify
sequences that can internally initiate translation, but it
does not indicate the role of an IRES in a monocistronic
mRNA, the context in which the IRES is normally found
in cellular mRNA. Consequently, two approaches were
utilized to determine whether the FMR1 IRES is a major
contributor to the translation of a monocistronic capped
mRNA. Initially, in vitro transcribed monocistronic mRNA
containing the Photinus  luciferase open reading frame
(ORF) and the β-globin or FMR1 5' leader was translated
in rabbit reticulocyte lysate. The overall level of Photinus
luciferase synthesis was reduced by approximately 40%
when the FMR1 5' leader was present. This result is not
surprising since cap-dependent translation of a short
unstructured 5' leader (β-globin) is very efficient. Increas-
ing concentrations of cap analog were added to the lysate
to compete with the cap structure for eIF-4E and inhibit
cap-dependent translation. Translation of the mRNA con-
taining the β-globin 5' leader decreased as the concentra-
tion of cap analog increased (Fig. 2B). This result
demonstrates that the β-globin mRNA is being translated
in a cap-dependent manner. On the other hand, transla-
tion of the mRNA containing the FMR1 5' leader was only
moderately affected (Fig. 2B); translation of the Photinus
luciferase cistron decreased by only 15% at the highest
The FMR1 5' leader exhibits putative IRES-activity, but also  contains a cyrptic promoter Figure 1
The FMR1 5' leader exhibits putative IRES-activity, 
but also contains a cyrptic promoter. (A) Dicistronic 
luciferase DNA constructs containing the multiple cloning 
site (MCS) from pRF, the 5' leader from the β-globin or 
FMR1, or the EMCV IRES inserted into the intercistronic 
region were transfected individually into C6 cells. Luciferase 
activity is shown as the ratio of Photinus luciferase to Renilla 
luciferase (P:R) and is normalized to the activity obtained 
from the control construct, pRF. A P:R ratio that is above 
that obtained from pRF indicates the presence of an IRES. (B) 
Dicistronic luciferase DNA constructs containing the MCS 
from pRF, the β-globin or FMR1 5' leader or the EMCV IRES 
with or without the SV40 promoter were transfected into 
C6 cells. The Photinus luciferase activity from each transfec-
tion is shown. Each experiment was performed in triplicate, n 
= 3.BMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
Page 4 of 13
(page number not for citation purposes)
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concentration of cap analog. This result not only indicates
that the mRNA containing the FMR1 5' leader is being
translated in a cap-independent manner, but that it may
be the major mechanism for its translation.
To determine the role of the FMR1 IRES within a cell, cap-
dependent translation was inhibited ex-vivo. The 4E-Bind-
ing Protein 1 (4E-BP1) binds and sequesters eIF-4E pre-
venting cap-dependent translation [34], but
phosphorylation of 4E-BP1 decreases its affinity to eIF-4E.
Consequently, C6 cells were transfected with a construct
coding for a mutant of 4E-BP1 (4E-BPmut) with the two
key phosphorylation sites mutated (Thr – 37 – Ala/Thr –
46 – Ala) or a control plasmid [20]. Monocistronic con-
structs containing the β-globin, EMCV, or FMR1 5' leader
were co-transfected. In the presence of over-expressed 4E-
BPmut, the level of Photinus  luciferase activity derived
from the mRNA containing the β-globin 5' leader
decreased by 72% (Fig. 2C). However, translation from
the mRNAs containing the FMR1 or EMCV 5' leader only
decreased by 19% and 27%, respectively (Fig. 2C). Since
81% of the luciferase activity remains when cap-depend-
ent translation is inhibited, it indicates that IRES-depend-
ent translation may be the primary mechanism for
translation of the FMR1 mRNA in vivo.
Endogenous FMRP expression is unaffected by reducing 
cap-dependent translation
To examine whether IRES-dependent translation is uti-
lized for the synthesis of endogenous FMRP, cap-depend-
ent translation was inhibited by treating C6 cells with
rapamycin. The mammalian target of rapamycin (mTOR)
is a kinase that is a key link in the promotion of cap-
dependent translation by phosphorylating 4E-BP and p70
S6 kinase. Exposure to 20 nM rapamycin for 24 hrs actu-
ally led to a modest increase in FMRP expression (Fig. 3A).
Phosphorylation of p70 S6 kinase was abolished demon-
strating that the mTOR pathway was inhibited and the
expression level of eIF-4E was decreased indicating cap-
dependent translation was repressed (Fig. 3A). These
results indicate that FMRP can be expressed under condi-
tions in which cap-dependent translation is impeded.
In addition to inhibiting cap-dependent translation,
blocking mTOR activity can alter other cellular pathways
and indirectly alter translation. To more directly examine
whether IRES-dependent translation is utilized for the
synthesis of endogenous FMRP, cap-dependent transla-
tion was inhibited by knocking-down expression of eIF-
4E. C6 cells were exposed to a pool of siRNA (Dhar-
macon) directed against the eIF-4E mRNA or a nonsense
siRNA for 72 hr. Quantitation of Western blots showed
that eIF-4E expression was reduced by > 70% (Fig. 3B, C).
The level of the transcription factor JunB whose mRNA is
translated in a cap-dependent manner was also reduced
by > 75%. However, FMRP expression was decreased by
only 12% (Fig. 3B, C). The observations that FMRP
expression is maintained despite reduced levels of eIF-4E
or mTOR activity (detailed above) indicates that IRES-
dependent translation is likely a important contributor to
the synthesis of FMRP.
Multiple regions in the 5' leader contribute to FMR1 IRES 
activity
A deletional analysis was performed to identify regions in
the FMR1 5' leader important for IRES activity. Serial 5'
truncations ranging from 11 to 53 nt in length were cre-
ated. The abridged 5' leaders were inserted into the dicis-
tronic luciferase construct and in vitro transcribed mRNA
was transfected into C6 cells. The initial truncations
resulted in a loss of IRES activity. Truncating the nt from -
235 to -208 resulted in the largest decrease in IRES activity
with the resulting P:R ratio being only 1.5 fold over that
obtained from the β-globin control (Fig. 4A). Deleting an
additional 42 nt (-208 – -167) abolished all IRES activity.
Additional truncations of 46 nt (-166 – -121) actually led
to an increase in the P:R ratio of approximately 1.5 fold
over the control value. Further truncations of 53 and 13 nt
(-120 – -54) that encompassed the CGG repeats resulted in
a decrease and complete loss of IRES activity, respectively.
These results indicate that 1) the 5' end of the 5' leader is
important for wild-type IRES activity, 2) an internal
region may be inhibitory, and 3) the region including -
120 – -54 exhibits a basal level of IRES activity. Interest-
Ex vivo and in vitro studies demonstrating IRES activity mediated by the FMR1 5' leader Figure 2 (see previous page)
Ex vivo and in vitro studies demonstrating IRES activity mediated by the FMR1 5' leader. (A) Capped dicistronic 
luciferase RNA containing the 5' leader from the β-globin or FMR1 mRNA inserted into the intercistronic region was trans-
fected individually into C6 cells. Luciferase activity is shown as the ratio of Photinus luciferase to Renilla luciferase (P:R) and is 
normalized to the activity of the β-globin construct. The experiment was performed in triplicate, n = 3. (B) Monocistronic 
Photinus luciferase mRNA containing the β-globin or FMR1 5' leader was translated in rabbit reticulocyte lysate in the presence 
of increasing concentrations of cap analog. The initial level of Photinus luciferase activity from each monocistronic mRNA was 
normalized to 100. (C) Monocistronic Photinus luciferase constructs containing the β-globin, EMCV, or FMR1 5' leader were 
co-transfected with either a plasmid expressing hypophosphorylated 4E-BP1 or a control plasmid and assayed for luciferase 
activity. The activities obtained in cells co-transfected with 4E-BP1 is represented as a percentage of the activity obtained in 
cells co-transfected with the control plasmid. The experiment was performed in triplicate, n = 3.BMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
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ingly, this latter region encompasses the CGG repeats of
which nine are contained in the present 5' leader.
Changes in intracellular pH regulate the FMR1 IRES
To determine the regulatory elements in the FMR1 IRES,
C6 cells were exposed to 500 μM ameloride for 24 hrs to
block the Na+/H+ antiporter. Intracellular acidification
inhibits neural activity and is a model of an inactive neu-
ron [35]. The P:R ratio from the dicistronic mRNA con-
taining the full-length 5' leader dramatically decreased in
the presence of ameloride (Fig. 4A). However, only subtle
differences in the P:R ratio were observed from trunca-
tions of the 3' 208 nt. The minimal level of IRES activity
remained in the shorter leaders. This result implies that a
decrease in intracellular pH inhibits FMR1 IRES activity
and this effect is mediated by repressing the IRES-promot-
ing region located at the 5' end of the 5' leader.
The CGG repeats contribute to FMR1 IRES activity
The basal level of IRES activity exhibited in the 5' leader
containing the 3' 120 nt was not affected by changes in
intracellular pH. An additional truncation deleting the
CGG repeats abolished all IRES activity. To further charac-
terize the role of the CGG repeats in the FMR1 IRES, the
repeats were internally deleted within the full-length 5'
leader. Transfection of the dicistronic mRNA containing
the FMR1 5' leader with the CGG repeats deleted exhib-
ited an approximately 50% decrease in the P:R ratio com-
pared to the full-length 5' leader (Fig. 4B). This result
demonstrates the importance of the CGG repeats for inter-
nal initiation mediated by the FMR1 5' leader.
FMR1 IRES activity is affected by KCl and 
polyinosinic:polycytidylic acid
IRES-dependent translation is affected by multiple cellu-
lar stimuli [36]. We sought to determine whether the
FMR1 IRES is regulated by environmental stimuli which
Figure 3
FMRP expression is maintained when cap-dependent transla- tion is reduced by rapamycin or eIF-4E siRNA Figure 3
FMRP expression is maintained when cap-dependent 
translation is reduced by rapamycin or eIF-4E 
siRNA.(A) Lysates from untreated or rapamycin treated C6 
cells were analyzed for FMRP, phosphorylated p70 S6 kinase, 
and eIF-4E. Shown is a representative Western blot for each 
experiment, n = 3. (B) siRNA directed against eIF-4E or a 
nonsense siRNA were transfected into C6 cells for 72 hr. 
Lysates from these cells were analyzed for eIF-4E, FMRP, 
JunB and GAPDH. GAPDH was used as a loading control 
since it has an extended half-life. Shown is a representative 
Western blot for each experiment, n = 3. (C) Western blots 
of lysates from cells treated with eIF-4E or a nonsense 
siRNA. Expression level of the proteins were quantitated 
using ImageQuant software (n = 3) and were normalized to 
GAPDH levels.BMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
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Truncations and ameloride treatment identify regions in the FMR1 5' leader important for IRES activity Figure 4
Truncations and ameloride treatment identify regions in the FMR1 5' leader important for IRES activity. (A) 
Dicistronic luciferase mRNA containing the β-globin, FMR1, or serial 5' truncations of the FMR1 5' leader inserted into the 
intercistronic region were transfected into C6 cells. C6 cells were exposed to ameloride for 24 hr or untreated. Luciferase 
activity is shown as the P:R ratio and is normalized to the activity from the β-globin mRNA. (B) Dicistronic luciferase mRNA 
containing the full length FMR1 5' leader, FMR1 5' leader with an internal deletion of the CGG repeats (FMRΔCGG), or the β-
globin 5' leader inserted into the intercistronic region was transfected into C6 cells. Luciferase activity is shown as the P:R ratio 
and is normalized to the activity from the β-globin mRNA. Each experiment was performed in triplicate, n = 3.BMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
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regulate the processes in which FMRP participates. Neural
activity leads to translation of FMR1 mRNA [2,37] and we
modeled this phenomenon by treating cells with 50 mM
KCl for 30 or 150 min. The short KCl exposure led to a
32% increase in the P:R ratio from the dicistronic mRNA
containing the FMR1 5' leader (Fig. 5A). However, the
longer KCl treatment resulted in a 28% decrease in the P:R
ratio. Moreover, the FMR1 P:R ratio after the 150 min
treatment was only one-third higher than that obtained
from the control dicistronic mRNA. This result indicates
that cellular depolarization differentially affects FMR1
IRES activity depending upon its duration.
To examine whether KCl also affects FMRP expression,
Western blots were performed from lysates obtained from
the treated and untreated cells. Changes in endogenous
FMRP levels mirrored that observed from FMRP IRES (Fig.
5B, C). An increase of 58% was seen after a 30 min KCl
treatment, whereas a 150 min treatment led to a 40%
decrease in FMRP expression.
FMRP has been localized to the RNA-induced silencing
complex (RISC), a nuclease complex that mediates RNA
interference (RNAi). Deletion of FMRP leads to a loss of
RNAi [38]. To determine if the presence of double
stranded RNA affects FMR1 IRES activity, C6 cells were
exposed to 500 μg/ml of polyinosinic:polycytidylic acid
(poly I:C), a double stranded polyribonucleotide. After a
7 hr exposure to poly I:C., the FMR1 P:R ratio increased by
41% (Fig. 6A). This result indicates a possible positive
feedback mechanism to stimulate FMRP synthesis in
response to double stranded RNA and it predicts that
RNAi activity will increase FMR1 translation in an IRES-
dependent manner. Tempering this conclusion was that
expression of endogenous FMRP did not change after a 7
hr exposure to poly I:C (Fig. 6B, C). As was observed from
the KCl experiments, it is possible that FMRP expression
may be upregulated at different timepoints following poly
I:C exposure.
Discussion
In the present report we demonstrate that the FMR1 5'
leader contains an IRES whose activity is dependent upon
the 5' 45 nt as well as the CGG repeats in the 5' leader.
Moreover, our studies indicate that internal initiation may
be an important mechanism for the translation of the
FMR1 mRNA. This conclusion is supported by the obser-
vation that synthesis of FMRP is maintained when cap-
dependent translation is inhibited by knocking-down eIF-
4E expression or rapamycin treatment. In addition, multi-
ple stimuli differentially affect FMR1 IRES activity suggest-
ing that similar processes are dynamically regulating
FMR1 translation in the cell.
Exposure to KCl alters FMR1 IRES activity and FMRP expres- sion Figure 5
Exposure to KCl alters FMR1 IRES activity and FMRP 
expression. (A) Dicistronic luciferase mRNA containing the 
β-globin or FMR1 5' leader inserted into the intercistronic 
region was transfected into C6 cells and exposed to 50 mM 
KCl for 30 or 150 min. After seven hr the cells were assayed 
for Photinus and Renilla luciferase activity. (B) Lysates from 
cells treated in (A) were analyzed for FMRP and GAPDH (as 
a loading control) using Western blots. Shown is a represent-
ative Western blot; each experiment was performed in tripli-
cate, n = 3. (C) Protein expression was quantitated using 
ImageQuant software; FMRP levels were normalized to 
GAPDH expression.BMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
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Our results show that the FMR1 5' leader contains a cryp-
tic promoter, an observation that has been noted in other
5' leaders [31,39]. The presence of elements influencing
transcription is not surprising as transcriptional elements
are located throughout a gene. While the FMR1 5' leader
affects transcription when present as DNA, the same
region promotes internal initiation as RNA as deduced
from both in vitro and ex vivo experiments using monocis-
tronic and dicistronic mRNA. RNA for these assays was
produced from in vitro transcription and this process
could yield a FMR1 5' leader with a secondary structure
different than what occurs in the cell. Indeed, it is likely
that proteins including IRES transactivating factors
(ITAFs, see below) bind to the FMR1 5' leader and alter its
structure  in vivo. However, viral IRESes whose activity
depends extensively upon secondary structure yield
robust IRES activity from in vitro transcribed RNA [40,41]
and are suitable for structural analysis [42].
The CGG repeats, which are amplified in FXS, are evolu-
tionarily conserved in mammals [18]. We suggest that the
CGG repeats are retained due to their ability to promote
translation and specifically internal initiation of transla-
tion. This hypothesis is supported by evidence indicating
that mRNA containing the normal number of CGG
repeats translates at a higher level compared to mRNA
absent of the repeats or containing a higher number of
repeats [43]. Moreover, we found that deleting the CGG
repeats significantly decreased FMR1 IRES activity. The
mechanism by which the repeats affect IRES activity is
open to speculation. Secondary structure is important for
viral IRESes and their ability to recruit canonical factors
and the ribosome [44]. Minor changes in the RNA struc-
ture can dramatically alter viral IRES activity [45,46].
Since the 3' 120 nt are able to mediate internal initiation,
the ribosome must bind somewhere in this region and the
CGG repeats may create a structure conducive for ribos-
omal recruitment. On the other hand, it has been pro-
posed that expansion of the CGG repeats (~50 – 200) in
the Fragile X pre-mutation allele sequesters an RNA bind-
ing protein and indirectly affects the function of other
mRNAs [47]. Thus, the CGG repeats may bind an ITAF
that directly recruits the translational machinery or may
act as a molecular chaperone and alter the secondary
structure, which in turn recruits the translational machin-
ery.
Deletion of the 5' 45 nt (or more specifically the nt 18 –
45 from the 5' end) of the FMR1 5' leader yielded the larg-
est decrease in IRES activity. This segment is also very con-
served in mammals. In general, viral IRESes are greater
than 200 nt in length and it would be of interest if a sub-
stantially smaller RNA segment of the FMR1 5' leader
could internally initiate translation. This observation is
not unprecedented as we have found that a region of 50 nt
Exposure to poly I:C alters FMR1 IRES activity Figure 6
Exposure to poly I:C alters FMR1 IRES activity. (A) 
Dicistronic luciferase mRNA containing the β-globin or 
FMR1 5' leader inserted into the intercistronic region were 
transfected into C6 cells and exposed to 500 μg/ml of poly 
I:C. After seven hr the cells were assayed for Photinus and 
Renilla luciferase activity. (B) Lysates from cells treated in (A) 
were analyzed for FMRP and GAPDH (as a loading control) 
using Western blots. Shown is a representative Western 
blot; each experiment was performed in triplicate, n = 3. (C) 
Protein expression was quantitated using ImageQuant soft-
ware; FMRP levels were normalized to GAPDH expression.BMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
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in the 5' leader of the amyloid precursor protein yields
IRES activity (Beaudoin et al. submitted). However, the 5'
deletion analysis as discussed above indicates that the
ribosome binds further downstream. It is likely that the 5'
45 nt does not contain an IRES, but acts as an enhancer by
affecting downstream RNA secondary structure, perhaps
through protein binding. Of interest is a region of ten con-
tiguous nt (nt 33 – 42 from the 5' end) of which nine are
pyrimidines making this a potential binding site for the
polypyrimidine binding protein PTB) and its neural
homolog nPTB. PTB aside from its role in RNA splicing is
an important ITAF for many eukaryotic IRESes [48].
FMRP is synthesized in response to neural activity [2,37]
and in particular, a brief exposure to KCl stimulates FMR1
synthesis in neuronal dendrites [49]. In our study, both
internal initiation mediated by the FMR1 5' leader and
FMRP expression were also regulated by the duration of
KCl exposure; a short exposure increased and a longer
exposure decreased FMR1 IRES activity and FMRP expres-
sion. Moreover, intracellular acidification associated with
decreased neural activity also inhibited FMR1 IRES activ-
ity. These results suggest that neural activity of differing
intensity or duration may produce distinct changes in
IRES-dependent translation mediated by the FMR1 5'
leader and that IRES-dependent translation is a mecha-
nism contributing to the synthesis of FMRP in neurons.
These results also indicate that a feedback mechanism
exists that is dependent upon the duration of the calcium
influx through voltage gated calcium channels stimulated
by KCl. Indeed, extent and duration of intracellular cal-
cium can regulate the translation of other mRNAs [50,51].
FMRP is associated with the RISC complex [7,8] and our
results indicate that the presence of double stranded RNA
stimulates IRES-dependent synthesis of FMRP. This result
implicates a positive feedback mechanism regulating the
synthesis of FMRP and the level of FMRP could regulate
the activity or the targets of the RISC complex. However,
the overall level of FMRP was not altered after poly I:C
exposure. Poly I:C leads to phosphorylation of eIF-2α [52]
and a subsequent decrease in cap-dependent translation
[53]. It is possible that the loss of any cap-dependent
translation of the FMR1 mRNA is compensated by an
increase in IRES-dependent translation, but the global
level of FMRP is unaffected.
Conclusion
In summary, we demonstrated that the FMR1 5' leader
contains an IRES, whose critical elements include the
CGG repeats as well as the 5' end of the leader. Inhibiting
cap-dependent translation in vitro and ex vivo resulted in
only a small diminution in the translation of reporter
mRNAs containing the FMR1 5' leader. Under similar con-
ditions, endogenous FMRP expression was maintained.
Multiple stimuli altered internal initiation of translation
mediated by the FMR1 5' leader that in some cases mirrors
that of FMRP synthesis in vivo. Taken together, our study
indicates that IRES-dependent translation of the FMR1
mRNA may be a major contributor to the synthesis of
FMRP in vivo.
Methods
Constructs
The FMR1 5' leader was PCR amplified from a human
brain cDNA library (Clontech) and inserted into the dual
luciferase vector – pRF [54,55] (a generous gift from Dr.
Anne Willis, University of Leicester) with EcoRI and NcoI
restriction endonuclease sites. The promoterless construct
was created by digesting the dicistronic construct with
SmaI and EcoRV and religating the construct. The mono-
cistronic vector for the ex vivo experiments was created by
digesting the RP vector with EcoRI and BamHI. The digest
released the 5' leader, the Photinus luciferase gene, and the
SV40 3' UTR, which were cloned into the pGL3 vector
(Promega). The monocistronic vector for the in vitro
experiments was created by inserting the above Photinus
gene into the SK+ Bluescript vector (Stratagene) down-
stream of a T7 promoter.
Serial truncations were produced by PCR amplification
with 5' and 3' primers containing EcoRI and NcoI endo-
nuclease restriction sites, respectively. Deletion of the
CGG repeats was accomplished by amplifying the region
3' to the repeats in the FMR1 5' leader and inserting it into
the pRF construct with EcoRI and NcoI restriction sites on
the 5' and 3' end, respectively. The 5' leader upstream of
the CGG repeats was amplified and inserted upstream of
the 3' FMR1 5' leader using EcoRI restriction sites. In
experiments using a hypophosphorylated form of 4E-BP1
(containing Thr-37-Ala/Thr-46-Ala mutations), plasmids
expressing this protein or the parent vector (both based
on pACTAG-2) were co-transfected with the monocis-
tronic constructs described above, using a 8-fold molar
excess of the 4E-BP1 or control expression constructs [20].
The 4E-BP1 double mutant and control expression plas-
mids were generously provided by Dr. Nahum Sonenberg
(McGill University, Montreal).
In Vitro Translation
The Bluescript SK+ vector containing the 5' leaders
upstream of the Photinus luciferase gene was linearized
with BamHI and in vitro transcribed using mMessage
Machine (Ambion) producing capped mRNA. The mRNA
was extracted with phenol/chloroform and a sample was
run on an agarose gel to ensure RNA integrity. 0.5 μg of
the mRNA and 1.6 nM methionine was added to rabbit
reticulocyte lysate (Speed Read, Novagen) and incubated
for 1 hr at 30°C in the presence or absence of cap analogBMC Molecular Biology 2008, 9:89 http://www.biomedcentral.com/1471-2199/9/89
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(Ambion). The sample was subsequently assayed for
Photinus luciferase activity.
Cell Culture/Luciferase Assays
C6 cells were obtained from ATCC and cultured in
DMEM, 10% fetal bovine serum and 2 mM L-glutamine.
Polyinosinic:polycytidylic acid, ameloride, and KCl were
obtained from Sigma. Cells were transfected with 2 μg of
DNA using Fugene transfection reagent (Roche) or 4 μg of
mRNA using the TransMessenger RNA transfection rea-
gent (Qiagen) according to the manufacturer's directions.
The RNA was in vitro transcribed using the mMessage
Machine (Ambion) and purified as detailed above. After
24 hr (DNA transfections) or 7 hours (RNA transfections),
the cells were lysed with 500 μl of lysis buffer (Promega).
Forty μl of the supernatant were used for the luciferase
assays using the Dual-Luciferase Reporter Assay System
and analyzed in a Luminoskan luminometer. For the
siRNA experiments, C6 cells were transfected with 10
pmol of rat siRNA targeted against eIF-4E (On-Target plus
SMARTpool, cat# L-0088826-01, Dharmacon) or non-
sense siRNA (Dharmacon) using INTERFERin siRNA
transfection reagent (Polyplus-Transfection) as directed
by the manufacturer. Cells were lysed with 200 μl of lysis
buffer (Promega) including phosphatase (Pierce) and
protease (Roche) inhibitors after 72 hours. The cell lysates
were analyzed by Western blot.
Western blot analysis
Cells were harvested in cell lysis buffer (Promega) with
protease (Roche) and phosphatase inhibitors (Pierce).
The cell lysate was analyzed by Western blot by separating
the proteins on a 12% SDS-polyacrylamide gel and trans-
ferred onto nitrocellulose. The membranes were blocked
(Invitrogen) and probed with a monoclonal antibody
(7G-1, 1:1000 dilution; Developmental Hybridoma
Bank) or a polyclonal antibody (sc-28739, 1:200 dilution;
Santa Cruz) directed against FMRP. Both antibodies
mainly recognized a single band at approximately 80 kD
in lysates from C6 cells and rat hippocampus (see Addi-
tional file 1). In addition monoclonal antibodies directed
against phosphorylated p70 S6 kinase (9206,1:1000 dilu-
tion; Cell Signaling) and eIF-4E (610269; 1:500 dilution,
BD Biosciences) or polyclonal antibodies directed against
JunB (Ab31421, 1:500 dilution; Abcam), and GAPDH (sc-
25778, 1:200 dilution; Santa Cruz) were used in 5% non-
fat dried milk in a solution of PBS containing 0.1% Tween
20. The blots were then incubated with alkaline phos-
phatase-conjugated secondary antibodies (1:10,000 –
1:50,000 dilution; Invitrogen) for 1 hour. Immunoreac-
tive bands were detected using chemiluminescence (Invit-
rogen) as per manufacturer's directions. Westerns blots
were either from individual PAGE gels (Fig. 3A) or the
nitrocellulose was restripped and reprobed (Figs. 3B, 5B,
6B). The Western blots were quantitated using Image-
Quant software (Applied Biosystems).
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